Home › Overweight › Florida
Overweight clinical trials in Florida
60 studies for Overweight are looking for participants at sites in Florida.
Cities in Florida
- Orlando27 studies
- Miami23 studies
- Jacksonville19 studies
- Deltona12 studies
- Hialeah10 studies
- St. Petersburg9 studies
- The Villages9 studies
- Pembroke Pines8 studies
- Ocala7 studies
- Tampa7 studies
- Davie7 studies
- Clearwater6 studies
- Doral6 studies
- Boca Raton6 studies
- West Palm Beach6 studies
- Town 'n' Country5 studies
- Leesburg4 studies
- Miramar4 studies
- Pensacola4 studies
- Naples4 studies
- Cape Coral3 studies
- Hollywood3 studies
- Spring Hill3 studies
- Sunrise3 studies
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Southern Clinical Research, Miami
- Research Institute of South Florida, Miami
- Clinical Neuroscience Solutions LLC, Orlando
- and 2 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Nov 9, 2026 · NCT07871409A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Jacksonville
- Research Site, Jacksonville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Tampa Bay Medical Research, Inc., Clearwater
- Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
- Progressive Medical Research, Port Orange
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351058Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Alliance for Multispecialty Research (AMR) Clinical Miami, Doral
- AMR Clinical - Fort Myers, Fort Myers
- AGA Clinical Trials, Hialeah
- and 6 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07685808Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- University of Florida Department of Medicine, Gainesville
- Aga Clinical Trials, Hialeah
- South Florida Clinical Research, Margate
- and 7 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Nov 6, 2026 · NCT07575399A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- DM Clinical Research, Bradenton
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07823608A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
- Westside Center for Clinical Research, Jacksonville
- Jacksonville Center for Clinical Research, Jacksonville
- Suncoast Clinical Research, New Port Richey
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07845500Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
- Bioclinical Research Alliance, Miami
- Indago Research and Health Center, Miami Lakes
- Clinical Research Center Of Florida, Pompano Beach
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07866066A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- Suncoast Clinical Research, New Port Richey
- Progressive Medical Research, Port Orange
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07843498A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- Clinical Research of West Florida, Inc., Clearwater
- Universal Axon Clinical Research LLC, Doral
- Westside Center for Clinical Research, Jacksonville
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07919678A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Excel Medical Clinical Trials, Boca Raton
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Age Medical Research Corporation, Miami
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Nature Coast Clinical Research, Crystal River
- West Coast Eye Institute, Lecanto
- South Broward Research, Miramar
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- American Research Centers of Florida, Pembroke Pines
- Encore Medical Research - Weston, Weston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07881458A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- NeoClinical Research, Hialeah
- Skin Care Research, Hollywood
- Encore Medical Research, Hollywood
- and 2 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06857942A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Arrow Clinical Trials, Daytona Beach
- Care Access - Delray Beach, Delray Beach
- Fleming Island Center for Clinical Research, Fleming Island
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- JEM Research Institute, Atlantis
- AMR Clinical, Doral
- Northeast Research Institute (NERI), Fleming Island
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Westside Center for Clinical Research, Jacksonville
- Care Access - St. Petersburg, St. Petersburg
- Conquest Research, Winter Park
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- and 3 more
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 4, 2026 · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Flourish Research - Miami, LLC, Miami
- PharmaDev Clinical Research Institute, LLC, Miami
- Emerald Coast Neurology - Airport Boulevard, Pensacola
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07369011Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- and 3 more
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 4, 2026 · NCT06937086A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
- International Research Associates LLC, Miami
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07915609A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
- All Childrens Hospital, St. Petersburg
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Nov 4, 2026 · NCT06672549A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Renstar Medical Research, Ocala
- Oviedo Medical Research, Oviedo
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 4, 2026 · NCT06897475Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
- Fortrea Clinical Research Unit - Daytona Beach, Daytona Beach
- AGA Clinical Trials, Hialeah
- K2 Medical Research Orlando, Maitland
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Nov 2, 2026 · NCT07908316A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Clearwater
- Research Site, Jacksonville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07784725A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Doral
- Research Site, Fleming Island
- Research Site, Fort Lauderdale
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07784270Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Innovative Research of West Florida /ID# 281963, Clearwater
- Northeast Research Institute (NERI) /ID# 282015, Fleming Island
- Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740, Jacksonville
- and 10 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- DM Clinical Research, Bradenton
- DM Clinical Research, Doral
- Clinical Neuroscience Solutions, Orlando
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 26, 2026 · NCT07837973A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Clearwater
- ACCOMPLISH-2 Research Site, Fort Myers
- ACCOMPLISH-2 Research Site, Jacksonville
- and 5 more
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Oct 20, 2026 · NCT07654374Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- Northeast Research Institute, Fleming Island
- Jacksonville Ctr For Clin Res, Jacksonville
- Center for Diab,Obes & Metab, Pembroke Pines
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT07607587Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
RecruitingObservational studyHealthy volunteers welcome
Ages 50 to 95 · All sexes · Updated Oct 15, 2026 · NCT06604650A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- Fortrea Clinical Research Unit, Daytona Beach
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Oct 8, 2026 · NCT07808073A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- New Horizon Research Center, Miami
- Indago Research & Health Center, Inc, Miami Lakes
- Suncoast Clinical Research, Inc., New Port Richey
- and 2 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 8, 2026 · NCT07589608A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
- Fortrea Clinical Research Unit, Daytona Beach
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 60 · Women · Updated Oct 8, 2026 · NCT07808060Breathing & Blood Pressure
- Florida State University, Tallahassee
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 45 · All sexes · Updated Oct 7, 2026 · NCT05632406A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- New Horizon Research Center, Miami
- Indago Research & Health Center, Inc, Miami Lakes
- Suncoast Clinical Research, Inc., New Port Richey
- and 2 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 7, 2026 · NCT06143956A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease
- Progressive Medical Research, Port Orange
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Oct 7, 2026 · NCT07843472AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- DM Clinical, Bradenton
- Essence MD Research, Naples
- Palm Beach Research Center, West Palm Beach
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT07571109Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Jacksonville Center for Clinical Research, Jacksonville
- Clinical Neuroscience Solutions - Jacksonville, Jacksonville
- South Florida Wellness and Clinical Research Institute, Lauderhill
- and 8 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 5, 2026 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- San Marcus Research Clinic Inc, Miami
- Optimus U Corporation, Miami
- Indago Research and Health Center, Miami Lakes
- and 3 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 5, 2026 · NCT07684144From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.